Breast Neoplasms: all 12,820 studies

Page 39 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)CompletedNCT01990209Phase 2Results posted
• A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)CompletedNCT01989676Phase 3Results posted
• Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)CompletedNCT01988571Phase 2Results posted
• High Dose Vitamin D vs Standard Dose Vitamin D StudyTerminatedNCT01988090Phase 2Results posted
• F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast CancerCompletedNCT01985971Not applicableResults posted
• A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerCompletedNCT01966471Phase 3Results posted
• Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast CancerCompletedNCT01964924Phase 2Results posted
• Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT01961544Phase 4Results posted
• Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast CancerCompletedNCT01959490Phase 2Results posted
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerCompletedNCT01958021Phase 3Results posted
• Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT01953003Phase 3Results posted
• Denosumab for Breast Cancer With Bone MetsTerminatedNCT01952054Phase 2Results posted
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)CompletedNCT01945775Phase 3Results posted
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)CompletedNCT01942135Phase 3Results posted
• A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerCompletedNCT01940497Phase 3Results posted
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTerminatedNCT01938833Phase 1/2Results posted
• Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast CancerTerminatedNCT01937507Phase 2Results posted
• Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerActive, not recruitingNCT01937117Phase 2Results posted
• Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial MetastasesTerminatedNCT01934894Phase 2Results posted
• Effect of Vandetanib on Cellular Markers in Invasive Breast CancerTerminatedNCT01934335Phase 2Results posted
• FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast CancerTerminatedNCT01931709Not applicableResults posted
• NECTAR Everolimus Plus Cisplatin in Triple (-) Breast CancerCompletedNCT01931163Phase 2Results posted
• A Study to Evaluate the Use of Supine MRI Images in Breast Conserving SurgeryCompletedNCT01929395Not applicableResults posted
• Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast CancerStatus unknownNCT01928680Phase 2Results posted
• A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerTerminatedNCT01928615Phase 2Results posted
• FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerCompletedNCT01928186Not applicableResults posted
• A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)CompletedNCT01926886Phase 3Results posted
• Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense BreastsCompletedNCT01925170Not applicableResults posted
• Estradiol Levels in Patients Treated With EstringCompletedNCT01923298Phase 2Results posted
• Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal WomenCompletedNCT01923168Phase 2Results posted
• Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody TherapyCompletedNCT01922921Phase 1/2Results posted
• A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)TerminatedNCT01919229Phase 2Results posted
• GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerTerminatedNCT01918306Phase 1/2Results posted
• Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast CancerTerminatedNCT01912963Phase 2Results posted
• Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerCompletedNCT01908101Phase 2Results posted
• A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsTerminatedNCT01905592Phase 3Results posted
• Cardiac Safety Study in Patients With HER2 + Breast CancerCompletedNCT01904903Phase 2Results posted
• Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast CancerCompletedNCT01901146Phase 3Results posted
• Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural CatheterTerminatedNCT01900730Phase 2Results posted
• Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancerTerminatedNCT01897441Not applicableResults posted
• Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerCompletedNCT01896050Results posted
• PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast CancerCompletedNCT01892540Not applicableResults posted
• A Study Of PF-06263507 In Patients With Advanced Solid TumorsTerminatedNCT01891669Phase 1Results posted
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerCompletedNCT01889238Phase 2Results posted
• Capecitabine With Digoxin for Metastatic Breast CancerTerminatedNCT01887288Phase 2Results posted
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)CompletedNCT01881230Phase 2/3Results posted
• Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast CancerCompletedNCT01880541Not applicableResults posted
• A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerTerminatedNCT01876251Phase 1Results posted
• Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast CancerCompletedNCT01875367Phase 3Results posted
• Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerTerminatedNCT01873833Phase 2Results posted
• BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast CancerCompletedNCT01870505Phase 1Results posted
• Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast CancerCompletedNCT01869764Phase 2Results posted
• Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerTerminatedNCT01868503Phase 2Results posted
• A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and SurgeryCompletedNCT01864746Phase 3Results posted
• Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast CancerTerminatedNCT01861054Phase 2Results posted
• Decision Support Workshop for Breast ReconstructionCompletedNCT01857882Not applicableResults posted
• Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy RadiationCompletedNCT01856543Phase 3Results posted
• Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast CancerCompletedNCT01855828Phase 2Results posted
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)CompletedNCT01853748Phase 2Results posted
• Computed Tomography Versus Standard 2D Mammography Versus 3D TomosynthesisCompletedNCT01852032Not applicableResults posted
• Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsCompletedNCT01849250Phase 2Results posted
• Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyCompletedNCT01847001Phase 2Results posted
• Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended BreastCompletedNCT01841749Results posted
• A Trial of a Comprehensive Breast Cancer Treatment Patient Decision ToolCompletedNCT01840163Not applicableResults posted
• APBI Proton Feasibility and Phase II StudyCompletedNCT01839838Phase 1/2Results posted
• Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 TumorsCompletedNCT01831076Phase 2Results posted
• Breast Cancer Risk Reduction: A Patient Doctor InterventionCompletedNCT01830933Not applicableResults posted
• Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast CancerCompletedNCT01828021Phase 2Results posted
• Eribulin in HER2 Negative Metastatic BrCaCompletedNCT01827787Phase 2Results posted
• Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast CancerCompletedNCT01827163Phase 2Results posted
• A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Active, not recruitingNCT01824836Not applicableResults posted
• Dietary Fat, Eicosanoids and Breast Cancer RiskCompletedNCT01824498Not applicableResults posted
• COGNUTRIN in Breast Cancer SurvivorsCompletedNCT01823991Early Phase 1Results posted
• A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerTerminatedNCT01823835Phase 1/2Results posted
• Feasibility Study of Meso BioMatrix Device for Breast ReconstructionCompletedNCT01823107Not applicableResults posted
• Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyCompletedNCT01819233Not applicableResults posted
• Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT01818063Phase 2Results posted
• Breast VCEUS to Evaluate Early Response to Neoadjuvant ChemotherapyTerminatedNCT01817374Not applicableResults posted
• NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast CancerCompletedNCT01816594Phase 2Results posted
• Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsCompletedNCT01814397Results posted
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic SettingCompletedNCT01808573Phase 3Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Ketorolac in Breast Cancer SurgeryCompletedNCT01806259Phase 3Results posted
• Melatonin Versus Placebo in Breast CancerCompletedNCT01805089Early Phase 1Results posted
• MRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerCompletedNCT01805076Phase 3Results posted
• Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AICompletedNCT01797120Phase 2Results posted
• Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCaCompletedNCT01796197Phase 2Results posted
• AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)CompletedNCT01791985Phase 1/2Results posted
• BKM120 For Triple Negative Breast CancerCompletedNCT01790932Phase 2Results posted
• A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.CompletedNCT01783444Phase 2Results posted
• Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTUCompletedNCT01781299Phase 4Results posted
• Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor CellsTerminatedNCT01779050Phase 2Results posted
• XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast CancerCompletedNCT01777945Results posted
• AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast CancerCompletedNCT01777932Results posted
• Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTerminatedNCT01776008Phase 2Results posted
• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)CompletedNCT01772472Phase 3Results posted
• Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast CancerCompletedNCT01771666Phase 2Results posted
• A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer PatientsCompletedNCT01764022Phase 3Results posted
• DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast CancerCompletedNCT01763931Phase 2Results posted
• NSAID Effects on Clinical and Imaging Breast BiomarkersCompletedNCT01761877Phase 2Results posted

← Breast Neoplasms overview